Sen. Warren pitches a Big Pharma 'swear jar'; U.K. biotech VC jumped 41% in 2014;

@FierceBiotech: EuroBiotech: EU IPOs obliterate recent highs, U.K. VC funding tops $700M, Woodford backs microbiome play. Report | Follow @FierceBiotech

@JohnCFierce: Interviewed the CEO at the new CAR-T player. Their CSO also worked on Bellicum program. Story | Follow @JohnCFierce

@DamianFierce: $MDCO's Clive Meanwell has by far the best name among biopharma CEOs. At least until someone appoints Guy Smiley. | Follow @DamianFierce

> Sen. Elizabeth Warren (D-MA) has a novel plan for punishing Big Pharma malfeasance: Drugmakers that settle federal criminal charges would have to bequeath 1% of their annual profits to the National Institutes of Health for 5 years thereafter. "It's like a swear jar," Warren said. More

> Former Chimerix ($CMRX) CEO Kenneth Moch, once at the center of a compassionate use controversy over the company's antiviral treatment, unexpectedly stepped down last year. Bloomberg Businessweek takes a detailed look at just what happened. Item

> U.K. life sciences firms banked about $713 million in venture capital last year, according to CB Insights, a 41% jump over 2013. News

Medical Device News

@FierceMedDev: Roche's Ventana inches closer to FDA approval for lung cancer companion Dx. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Welch Allyn buys eye exam provider, signaling move into services. Article | Follow @VarunSaxena2

@EmilyWFierce: Au revoir, Weber; Bonjour, Bohuon? FiercePharma article | Follow @EmilyWFierce

> Profit down 12% at Intuitive Surgical, but procedure volume up due to strength abroad and in general surgery. More

> France's bioMérieux and Astute Medical join forces on acute kidney injury test. Article

Pharma News

@FiercePharma: ICYMI yesterday: Pfizer wins recommendation for Prevenar expansion in Europe. Story | Follow @FiercePharma

@EricPFierce: UAE-based Gulf Pharmaceuticals intends to build a $50M insulin plant in Ethiopia. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Ex-Sanofi chief Viehbacher makes a $5M-plus severance deal. Article | Follow @CarlyHFierce

> Challenger says 2015 a year to send out your resume, pharma folk. Story

> GSK refutes reports the ax is about to fall on jobs in China. News

Suggested Articles

The data, from two patients with severe blood disorders, are "promising” for what could be a one-and-done treatment, Cantor Fitzgerald analysts wrote.

The fund will back pharma companies as well as developers of medtech products and providers of outsourced services.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.